One item to point out from a mix standpoint circle, a well positioned ASC like hospital enterprise and England has an SG&A rate in the '30s on service fee revenue of approximately $1.4 billion.
In Medicaid our business continues to perform well, membership increased to $14.8 million aided by continued suspension of redeterminations and the go-live of our business in North Carolina.
In the quarter, we generated revenue of $32.4 billion and HBR of 88.1% and adjusted earnings per share of $1.26.
We do not plan to replace his position, as we continue to work on refreshing and streamline the Board to a size of 9 to 13 members.
With respect to unregulated cash we had $2.7 billion at quarter end, which includes the $1.8 billion we borrowed to partially fund the Magellan transaction.
Our Q3 consolidated HBR was 88.1%, right on track with our full year guidance.
At the end of the third quarter our marketplace membership was $2.2 million, and we are pleased with the progress of our clinical initiatives as we head into the fourth quarter.
Beginning in 2022, the company expects to offer plans in 327 new counties, representing a 26% increase and three new states including Massachusetts, Nebraska and Oklahoma.